Roche’s eye implant may reduce vision loss treatment time for seniors
By
Alicia Lasek
Oct 26, 2021
The FDA has approved an ocular implant that could reduce the treatment schedule from monthly to twice yearly for older adults with “wet” macular degeneration.
Lung cancer mutation test approved
May 29, 2013
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.